Gene Solutions, a pioneer in AI-driven precision oncology hosted K-CONNECT APAC 2025, a pivotal summit uniting over 100 ...

Technical decisions that advance inference capabilities can help deliver the promise of ubiquitous, accessible AI.

Cathie Wood of Ark Invest recently highlighted new research from Mass General Brigham, where AI models were able to predict cancer survival outcomes based on facial images—an example she cited as ...

In the past, most targeted drug development efforts relied on single biomarkers, but cancer is far more complex. BostonGene’s ...

Philadelphia-based biotech Vivodyne has raised $40 million in series A funding to advance its fully robotic, AI-powered ...

Veeva Systems Inc (($VEEV)) has held its Q1 earnings call. Read on for the main highlights of the call. Veeva Systems Inc. recently held its ...

Despite the advancement of AI and machine learning technologies and their incorporation into cancer treatment and drug development, a lack of trust and understanding of these new approaches is ...

Today’s hospitals and health systems are plagued by a conundrum: providers have too much data, but not enough data insights.

In an era where precision medicine is redefining the foundations of healthcare, Sambasiva Rao Suura emerges as a pione ...

From mRNA breakthroughs to cloud-based analytics, sector specialists outline the technological innovations and skills ...

Cell.Ai, a precision oncology company developing advanced cell and molecular profiling platforms, announced the successful completion of a CLIA-grade analytical validation study of its OncoIncytes ...

Biopharma Industry Landscape Report—uncover key trends in obesity, oncology, immunology, and AI, plus top stock picks and ...